Lonza has developed and launched a new performance nutrition brand, Oceanix, in the U.S. and Canada. The unique phytoplankton ingredient is sustainably sourced from the ocean and meets rising demand for natural, non-GMO and vegan supplement products, according to the company.
 
Containing highly active antioxidant enzymes, including superoxide dismutase (SOD), as well as essential fatty acids, vitamins, amino acids and minerals, the Oceanix ingredient offers potential benefits for physical performance and an increased physiological response against oxidative stress to aid recovery in a small, concentrated dose. 
 
Shane Durkee, vice president, platform innovation, R&D, Lonza Consumer Health, commented: “Our goal is to consistently challenge the status quo by always developing innovative, science-backed products that meet the needs of our customers and our consumers. With its vegan origins, the Oceanix ingredient brings sports performance and wellness benefits together, appealing to a new set of consumers.” 
 
He added, “More and more consumers are pushing their physical performance, both in terms of intensity and the duration of activity. These consumers want effective performance nutrition to support performance and recovery that’s also clean label, non-GMO, high quality and clinically studied. Oceanix phytoplankton ingredient delivers on these consumer demands in a small, effective, once-a-day 25 mg dose.”
 
Produced using patent-pending technology, the Oceanix brand is suitable for use in a variety of sports nutrition applications, including dietary supplements, bars, drinks and powders.